USA Today20d
Diabetes patients worry about insulin shortages as Ozempic use skyrockets
Three drug companies dominate the U.S. insulin market: Novo Nordisk, Eli Lilly and Sanofi. Last spring, Eli Lilly reported its drugs Humalog and insulin lispro were in short supply. Novo Nordisk ...
Reuters13d
$35 insulin: Who in the US benefits?
A Lilly spokesperson said there are currently over 50,000 Lispro prescriptions filled weekly at U.S. pharmacies which can get ...
AZ Central20d
Diabetes patients worry about insulin shortages as Ozempic use skyrockets
Death is imminent," Wright said. Three drug companies dominate the U.S. insulin market: Novo Nordisk, Eli Lilly and Sanofi.
Explainer-Who in the US Benefits From $35 Insulin?
Nearly one-third of those patients were paying $35 or far more per month in 2019, according to the latest available data from ...
USA Today20d
As insulin shortages persist, what diabetes patients can do
Earlier this year, Eli Lilly reported temporary shortages of Humalog and insulin lispro in 10-milliliter ... are approved to treat weight loss. Drug companies have invested hundreds of millions ...
Yahoo20d
As insulin shortages persist, what diabetes patients can do
Earlier this year, Eli Lilly reported temporary shortages of Humalog and insulin lispro in 10-milliliter ... reported shortages of NovoLog insulin. Drug companies recommend patients check with ...